OleQuat
OleQuat is focused on developing a new class of olefinic quaternary ammonium compounds (oQACs) with broad-spectrum, anti-biofilm antimicrobial activity, reduced toxicity, and decreased environmental persistence. These compounds are intended for use as low-dose preservatives, high-performance surface sanitisers, and hold potential for future topical applications. The company is in the preclinical stage, with activities driven by scientific research and regulatory compliance.
Industries
N/A
Products
A new class of antimicrobial compounds designed for broad-spectrum, anti-biofilm activity with reduced toxicity and improved environmental profile. Applications include low-dose preservatives, surface sanitisers, and potential future topical therapeutics.
A new class of antimicrobial compounds designed for broad-spectrum, anti-biofilm activity with reduced toxicity and improved environmental profile. Applications include low-dose preservatives, surface sanitisers, and potential future topical therapeutics.
Expertise Areas
- Antimicrobial compound development
- Anti-biofilm agent research
- Microbiology and infection dynamics
- Medicinal chemistry
Key Technologies
- Olefinic quaternary ammonium compounds
- Broad-spectrum antimicrobial agents
- Anti-biofilm technologies
- Preclinical efficacy testing
Key People
Co-Founder | Chemistry
Co-Founder | Microbiology
Co-Founder | Commercial and CEO
Co-Founder | Chemistry
Co-Founder | Microbiology
Co-Founder | Commercial and CEO